Pandit-Taskar, Neeta* Dotaz Zobrazit nápovědu
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck paragangliomas, which, in almost 20% of patients, might coexist with paragangliomas arising from other locations (eg, adrenal medulla, para-aortic, cardiac or thoracic, and pelvic). Given the higher risk of tumour multifocality and bilaterality for phaeochromocytomas and paragangliomas (PPGLs) because of SDHD pathogenic variants than for their sporadic and other genotypic counterparts, the management of patients with SDHD PPGLs is clinically complex in terms of imaging, treatment, and management options. Furthermore, locally aggressive disease can be discovered at a young age or late in the disease course, which presents challenges in balancing surgical intervention with various medical and radiotherapeutic approaches. The axiom-first, do no harm-should always be considered and an initial period of observation (ie, watchful waiting) is often appropriate to characterise tumour behaviour in patients with these pathogenic variants. These patients should be referred to specialised high-volume medical centres. This consensus guideline aims to help physicians with the clinical decision-making process when caring for patients with SDHD PPGLs.
- MeSH
- feochromocytom * diagnóza genetika terapie MeSH
- lidé MeSH
- nádory nadledvin * diagnóza genetika terapie MeSH
- paragangliom * diagnóza genetika terapie MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- sukcinátdehydrogenasa genetika MeSH
- zárodečné mutace genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Research Support, N.I.H., Intramural MeSH
Hope, Amir Iravani, -- Neeta Pandit-Taskar, Babak Saboury, Sara St. James, and -- Pat B. Radiopharmaceutical Therapy -- of Cancer: Practicality Versus Perfection in Current -- Practice -- Neeta Pandit-Taskar, Amir Iravani, Dan Lee, Heather Jacene, -- Dan Pryma, Thomas Hope, Babak Saboury, Jacek Wahl -- Pandit-Taskar and colleagues review dosimetric approaches in -- radiopharmaceutical therapy and
The journal of nuclear medicine, ISSN 0161-5505 Volume 62, Supplementum 3, December 2021
79 stran : ilustrace ; 28 cm
The publication focuses on the methods of radiopharmaceutical dosimetry therapy in oncology. Intended for professional public.
- MeSH
- nádory terapie MeSH
- nukleární lékařství MeSH
- radiofarmacie MeSH
- radiofarmaka MeSH
- radiometrie MeSH
- Konspekt
- Lékařské vědy. Lékařství
- NLK Obory
- onkologie
- radiologie, nukleární medicína a zobrazovací metody
- farmacie a farmakologie
- NLK Publikační typ
- brožury